Order GP Test U500 Online
Active Substance: Testosterone Undecanoate
Manufacturer: Geneza Pharmaceuticals
Unit: 10 mL Vial (500 mg/ml)
Common Names
Testosterone Undecylate, Restandol, Nebido-R, Undestor, Reandron 1000, Andriol, Aveed, Nebido, Cernos Depot, Panteston, Androxon.
Drug Description
GP Test U500 Composition
Each 1 mL contains:
Active substance: Testosterone Undecanoate 500 mg
Bodybuilding Benefits
Therapeutic Indication
Dosage (Men)
250-1000 mg/week
Dosage (Women)
Active Life
1-12 Days
GP Test U500 Side Effects
GP Test U500 Contraindications/Precautionary Measures
Overdosage
GP Test U500 Stack/Cycle
Package Presentation
10 mL Vial.
Storage
To be store in a dry place, protected from light, at a temperature of 15-25 ° C. Keep out of reach of children.
GP Test U500 Referrers
Online GP Test U500 Reviews
No reviews found
Please log in to review GP Test U500
Buy GP Test U500 Related Offers
Undecanoate
Active Substance: Testosterone Undecanoate
Manufacturer: Dragon Pharma
Unit: 10 mL vial (250 mg/mL)
Undecanolab-250
Active Substance: Testosterone Undecanoate
Manufacturer: 7Lab Pharma
Unit: 10 mL Vial (250 mg/mL)
Nebido
Active Substance: Testosterone Undecanoate
Manufacturer: Bayer Schering
Unit: 1 mL amp (1000 mg/4mL)
Out of stock
GP Test U250
Active Substance: Testosterone Undecanoate
Manufacturer: Geneza Pharmaceuticals
Unit: 10 mL Vial (250 mg/ml)
Out of stock
Categories
Currency
Steroids Search
Latest Updates
-
Cycling Techniques
This simple, moderate, 12-Week Stack will result in tremendous gains in size and strength for the average male athlete. This stack is a combination of Anadroxyl and Deca-durabolin, ending with HCG and Clomid; it's a good starting point if you're a novice.
-
How to Inject
There are 4 of 5 places on the body suitable for intramuscularly injections. Find out which ones!
-
Dragon Pharma Legit
Dragon Pharma legit supplier offers quality anabolic steroids and fat burning products at affordable prices. Efficient injectable steroids for anabolic cycles and other powerful gear sold online.
